Likewise, a 5% reduction in weight in 35 NAFLD patients (14 lean and 21 with obesity) yielded significant improvements in ALT and AST levels, hepatic steatosis, and liver stiffness [138]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.